Chapter One — 1.1 Background to the Study

Access to Primary Healthcare has increasingly attracted the attention of researchers, regulators, and practitioners concerned with prevalence of non-communicable diseases. This growing interest reflects the recognition that access to primary healthcare does not operate in isolation, but interacts with a wider set of institutional and market conditions found within Sokoto State.

Within the context of Sokoto State, this relationship carries particular significance. Organizations in this setting operate under a distinct combination of economic, regulatory, and market conditions that may amplify or dampen the effect of access to primary healthcare on prevalence of non-communicable diseases, making a context-specific inquiry both timely and necessary.

1.2 Statement of the Problem

While access to primary healthcare is widely discussed in policy and industry circles, empirical evidence on its actual effect on prevalence of non-communicable diseases within Sokoto State remains sparse and, in places, contradictory. This lack of localized, rigorous evidence makes it difficult for decision-makers to know with confidence whether current approaches to access to primary healthcare are helping or hindering prevalence of non-communicable diseases — a gap this study sets out to close.

1.3 Objectives of the Study

1. To examine the effect of Access to Primary Healthcare on prevalence of non-communicable diseases in Sokoto State.
2. To assess the extent to which access to primary healthcare influences prevalence of non-communicable diseases within the study area.
3. To identify the challenges associated with access to primary healthcare in relation to prevalence of non-communicable diseases.
4. To recommend strategies for optimizing access to primary healthcare in order to improve prevalence of non-communicable diseases.

1.4 Research Questions

1. What is the effect of access to primary healthcare on prevalence of non-communicable diseases in Sokoto State?
2. To what extent does access to primary healthcare influence prevalence of non-communicable diseases within the study area?
3. What challenges are associated with access to primary healthcare in relation to prevalence of non-communicable diseases?
4. What strategies can be adopted to optimize access to primary healthcare in order to improve prevalence of non-communicable diseases?

1.5 Significance of the Study

This study is significant to a range of stakeholders. For policymakers and regulators, the findings offer evidence to guide the design of frameworks that support healthier outcomes around prevalence of non-communicable diseases. For managers and practitioners within Sokoto State, the study provides practical insight into how access to primary healthcare can be better managed. Finally, it contributes to the academic literature on public health by extending existing knowledge into a specific empirical context, and offers a reference point for future researchers.

1.6 Scope of the Study

The study is limited to an examination of Access to Primary Healthcare and its relationship with prevalence of non-communicable diseases within the context of Sokoto State. It reflects a clearly defined scope of analysis and relies on data and perspectives available within that scope; generalizing the findings beyond this specific context should therefore be done with appropriate caution.